Product Details
| Product Name: TAUROURSODEOXYCHOLIC ACID SODIUM SALT | CAS No.: 35807-85-3 |
| EC-No.: 1308068-626-2 | Min. Order: 1g |
| Purity: 99.99 | Supply Ability: 100000 |
| Release date: 2025/11/28 |
Chemical Properties
| Melting point | 173-175°C |
| alpha | +40~+50°(D/20℃) |
| storage temp. | Inert atmosphere,Store in freezer, under -20°C |
| solubility | DMSO (Slightly, Heated), Ethanol (Slightly, Sonicated), Methanol (Slightly) |
| form | Solid |
| color | Off-White to Pale Beige |
| Water Solubility | water: 100mg/mL |
| InChIKey | WSSCRQYICWZEFG-SXXADWEANA-N |
| SMILES | C[C@]12CC[C@]3([H])[C@]4(CC[C@@H](O)C[C@@]4([H])C[C@H](O)[C@@]3([H])[C@]1([H])CC[C@]2([H])[C@H](C)CCC(=O)NCCS(O)(=O)=O)C.[NaH] |&1:1,4,6,9,12,15,17,19,23,25,r| |
Safety Information
| WGK Germany | 2 |
| RTECS | KI7372500 |
| HS Code | 2924297099 |
Usage And Synthesis
Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways.
General Description
Sodium tauroursodeoxycholate is a bile salt which is naturally present in the small bowel.
The effects of Tauroursodeoxycholate (TUDCA) on proliferation and apoptosis of VSMCs in vivo are examined using immunohistochemistry. Tauroursodeoxycholate (10, 50, and 100 mg/kg) increases the caspase 3 activity of injured tissues in a dose-dependent manner, indicating that Tauroursodeoxycholate induces apoptosis of VSMCs in the neointima. Using the injured tissues, further examination and comparison of the phosphorylation level of ERK and MMP-9 expression is performed at 1 week after injury, compared with normal controls. Balloon injury increased both the phosphorylation of ERK and expression of MMP-9 in the tissues. Tauroursodeoxycholate (10, 50, and 100 mg/kg) inhibits phosphorylation of ERK and MMP-9 expression in a dose-dependent manner[1]. Tauroursodeoxycholate (TUDCA) is a hydrophilic bile acid. Tauroursodeoxycholate as a cytoprotective agent improves liver function and can prevent hepatocellular carcinoma by reducing ER stress and apoptosis. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3, caspase-12, C/EBP homologous protein, c-Jun N-terminal kinase (JNK), activating transcription factor 4 (ATF4), X-box binding protein (XBP), and eukaryotic initiation factor 2α (eIF2α) in Ang II induced ApoE-/- mice (p<0.05). Tauroursodeoxycholate reduces Angiotensin (Ang) II induced abdominal aortic aneurysm (AAA)? formation in ApoE-/- mice. Tauroursodeoxycholate is used at a dose of 0.5 g/kg/day in treating Ang II induced ApoE-/- mice (ER stress inhibitor group). Systolic blood pressure (141.3±5.6 mmHg vs 145.9±8.9 mmHg; p>0.05) and total cholesterol levels (663.6±88.7 mg/dL vs 655.7±65.4 mg/dL; p>0 .05) do not differ between the AAA model group and Tauroursodeoxycholate group. In addition, maximum aortic diameter is significantly smaller in those in Tauroursodeoxycholate group compared with those in the AAA model group (0.95±0.03 mm vs 1.79±0.04 mm; p<0.05). AAA lesion areas are also smaller in those in Tauroursodeoxycholate group than in those in the AAA model group (0.37±0.03 mm2 vs 1.51±0.06 mm2; p<0.05)[2].
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $30.00/25mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-11-04 | |
| $0.00/1kg |
VIP2Y
|
HANGZHOU HAILAN CHEMICAL CO.,LTD.
|
2025-10-24 | |
| $0.00/1KG |
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-21 | |
| $10.00/1kg |
Ouhuang Engineering Materials (Hubei) Co., Ltd
|
2024-04-29 | ||
| $0.00/1Kg |
airuikechemical co., ltd.
|
2024-04-08 | ||
| $45.00/1kg |
Sigma Audley
|
2024-03-11 | ||
| $0.00/20mg |
Shanghai Standard Technology Co., Ltd.
|
2019-12-26 | ||
| $1.00/1KG |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-11 |
- Since: 2024-12-18
- Address: No. 32 Binhai Avenue, Longhua District, Haikou City, Hainan Province, China

China